KEW Group

About:

KEW Group is a personalized oncology management company that provides DNA based genomic testing and interpretation services.

Website: https://kewinc.com

Twitter/X: KEWGroup

Top Investors: Signet Healthcare Partners, Amzak Capital Management, Arsenal Capital Management, The Bolyston Street Group, Cardinal Health

Description:

KEW Group is a personalized oncology management company that provides DNA based genomic testing and interpretation services. It will deploy proprietary oncology therapeutic pathways and personalized medicine tools, including genetic and genomic information, in the community oncology care setting, enabling the highest quality clinical care, efficiently delivered. It was founded in 2009 and is based in Cambridge, Massachusetts.

Total Funding Amount:

$32.9M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2009-01-01

Contact Email:

kewcustomercare(AT)kewinc.com

Founders:

Jeff Elton, Kathy Behrens Wilsey, Raju Kucherlapati

Number of Employees:

11-50

Last Funding Date:

2015-01-12

IPO Status:

Private

Industries:

© 2025 bioDAO.ai